Gene transfer for erectile dysfunction: Will this novel therapy be accepted by urologists?

Current Opinion in Urology

Volumn 19, Issue 6, 2009, Pages 595-600

  Melman, Arnold ^a   Rojas, Lorraine ^a   Christ, George ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Erectile dysfunction; Gene transfer; Maxi K; Naked DNA

Indexed keywords

HMAXI K; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NAKED DNA; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; DRUG USE; ERECTILE DYSFUNCTION; GENE TRANSFER; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TREATMENT OUTCOME; UROLOGY;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS, PHASE I AS TOPIC; ERECTILE DYSFUNCTION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MALE; UROLOGY;

EID: 70350066071     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283314985     Document Type: Review

References (12)

1. Melman A, Bar-Chama N, McCullough A, et al. hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006; 17:1165-1176.
2. Melman A. Gene therapy for male erectile dysfunction. Urol Clin North Am 2007; 34:619-630; viii.
3. Melman A, Davies KP, Bar-Chama N, et al. Short and long-term safety of six escalating doses of hMaxi-k as potential therapy for moderate to severe erectile dysfunction of diverse etiology. J Urol 2009; 181:487.
4. Christ GJ, Rehman J, Day N, et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 1998; 275:H600-H608.
5. Christ GJ, Spray DC, Brink PR. Characterization of K currents in cultured human corporal smooth muscle cells. J Androl 1993; 14:319-328.
6. Kay MA, High K. Gene therapy for the hemophilias. Proc Natl Acad Sci U S A 1999; 96:9973-9975.
7. Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24:257-261.
8. Kimmelman J. Staunch protections: the ethics of haemophilia gene transfer research. Haemophilia 2008; 14:5-14.
9. Marshall E. Gene therapy. Viral vectors still pack surprises. Science 2001; 294:1640.
10. Caplan A. Commentary: improving quality of life is a morally important goal for gene therapy. Hum Gene Ther 2006; 17:1164.
11. Christ GJ, Brink PR, Melman A, Spray DC. The role of gap junctions and ion channels in the modulation of electrical and chemical signals in human corpus cavernosum smooth muscle. Int J Impot Res 1993; 5:77-96.
12. Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54:346-351.